FDA Awards $1.1M Contract to CUBRC and EpiVax for Validation o...
- Written by LATEST ASIANET NEWS RELEASES
- Published in Asia Net
PROVIDENCE, Rhode Island, Oct. 22, 2020 /PRNewswire-AsiaNet/ -- EpiVax, Inc. ("EpiVax") and CUBRC, Inc. ("CUBRC") announced today that they have been awarded a two-year, $1.1 million contract from the Office of Generic Drugs (OGD) in the Center of Drug Evaluation and Research (CDER) of the Food and Drug Admini...
Authors: LATEST ASIANET NEWS RELEASES